European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
from Sanofi - Aventis Groupe https://ift.tt/ZdbTQ83
via IFTTT
Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease
https://ift.tt/y42DbGw
from Sanofi - Aventis Groupe https://ift.tt/ZdbTQ83
via IFTTT
from Sanofi - Aventis Groupe https://ift.tt/ZdbTQ83
via IFTTT
0 Comments
Please ,
Do not enter any kind of span link